Investors Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,118
Closed -$518K 57
2021
Q4
$518K Hold
1,118
0.24% 110
2021
Q3
$417K Hold
1,118
0.22% 120
2021
Q2
$427K Hold
1,118
0.23% 119
2021
Q1
$401K Hold
1,118
0.23% 112
2020
Q4
$359K Hold
1,118
0.24% 110
2020
Q3
$300K Buy
1,118
+50
+5% +$13.5K 0.22% 112
2020
Q2
$281K Hold
1,068
0.23% 108
2020
Q1
$242K Hold
1,068
0.24% 99
2019
Q4
$323K Buy
+1,068
New +$294K 0.26% 97

Other funds holding ELV

Investors Financial Group's ELV Position: Q1 2022 in Review

Investors Financial Group sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 1,118 shares — an estimated $518K sold.

Investors Financial Group first reported a position in ELV in Q4 2019 and held it in 9 quarters. The position peaked at $518K in Q4 2021. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Investors Financial Group reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
  • Investors Financial Group sold 1,118 Elevance Health shares in Q1 2022, an estimated $518K.
  • Investors Financial Group first reported a position in Elevance Health in Q4 2019 and held it in 9 quarters.
  • Investors Financial Group's Elevance Health position peaked at $518K in Q4 2021.
  • 1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.